Related references
Note: Only part of the references are listed.Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue
Michael J. Gerdes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dark pixel intensity determination and its applications in normalizing different exposure time and autofluorescence removal
Z. Pang et al.
JOURNAL OF MICROSCOPY (2012)
Next-generation biomarkers based on 100-parameter functional super-resolution microscopy TIS
Walter Schubert et al.
NEW BIOTECHNOLOGY (2012)
Prediction of outcome of early ER plus breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
E. K. A. Millar et al.
BRITISH JOURNAL OF CANCER (2011)
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
Jack Cuzick et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Coupled minimum-cost flow cell tracking for high-throughput quantitative analysis
Dirk Padfield et al.
MEDICAL IMAGE ANALYSIS (2011)
Multiplexed Assessment of the Southwest Oncology Group-Directed Intergroup Breast Cancer Trial S9313 by AQUA Shows that Both High and Low Levels of HER2 Are Associated with Poor Outcome
Malini Harigopal et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Multiplexed Analysis of Proteins in Tissue Using Multispectral Fluorescence Imaging
Eugene Barash et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Toponomics: studying protein-protein interactions and protein networks in intact tissue
Sandra Pierre et al.
MOLECULAR BIOSYSTEMS (2010)
Prognostic Value of Estrogen Receptor and Ki-67 Index after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Expressing High Levels of Proliferation at Diagnosis
L. Miglietta et al.
ONCOLOGY (2010)
Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification
Matteo Brunelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Quantitative multiplexed quantum dot immunohistochemistry
E. Sweeney et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Multiple immunoenzyme staining: Methods and visualizations for the observation with spectral imaging
Chris M. van der Loos
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer
P. H. Cottu et al.
ANNALS OF ONCOLOGY (2008)
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American society of clinical Oncology/College of American pathologists guidelines:: tumor heterogeneity in breast cancer and its implications for tissue Microarray based assessment of outcome
Christopher B. Moeder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quantitative analysis of estrogen receptor heterogeneity in breast cancer
Gina G. Chung et al.
LABORATORY INVESTIGATION (2007)
Intratumoral heterogeneity of HER2/neu in breast cancer -: A rare event
Wedad Hanna et al.
BREAST JOURNAL (2007)
Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures
Manuela Friedenberger et al.
NATURE PROTOCOLS (2007)
Analyzing proteome topology and function by automated multidimensional fluorescence microscopy
Walter Schubert et al.
NATURE BIOTECHNOLOGY (2006)
Share Paper
